This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n14http://linked.opendata.cz/resource/drugbank/drug/DB08467/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB08467/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n4http://linked.opendata.cz/resource/drugbank/drug/DB08467/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08467/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB08467/identifier/pubchem-substance/

Statements

Subject Item
n2:DB08467
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB08467 n12:DB08467
dcterms:title
6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID
adms:identifier
n4:RE9 n7:4451273 n10:5289278 n11:99444938 n14:DB08467
n5:IUPAC-Name
n6:271B5AFA-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5B00-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5AFF-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5AFC-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5AFD-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5AFE-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5AF8-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5AF6-363D-11E5-9242-09173F13E4C5 n6:271B5AF9-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5AF7-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5B06-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5B07-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5B01-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5B02-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5B04-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5B03-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5B05-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5B0B-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5B0D-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5B0E-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5B0A-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5B09-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5B0C-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5AFB-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5B08-363D-11E5-9242-09173F13E4C5